A double-blind, randomized, placebo-controlled study to evaluate the effect of leflunomide on HIV-1 associated immune proliferation in vivo

Trial Profile

A double-blind, randomized, placebo-controlled study to evaluate the effect of leflunomide on HIV-1 associated immune proliferation in vivo

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Leflunomide (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jul 2007 Status changed from recruiting to in progress.
    • 23 Aug 2006 The expected completion date for this trial is now .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top